18F-DCFPyL may be “one-stop shop” in detecting recurrence in prostate cancer with BCR
The PET agent targeting prostate specific membrane antigen (PSMA) 18F-DCFPyL effectively detected recurrent lesions in prostate cancer patients with biochemical recurrence.